Whitehawk Therapeutics (WHWK) Change in Receivables (2016 - 2025)
Whitehawk Therapeutics (WHWK) reported Change in Receivables of $1.0 million for Q1 2025, up 280.18% year-over-year from $263033.2 in Q1 2024, and up 256.99% on a QoQ basis from -$637000.0 in Q4 2024.
Whitehawk Therapeutics (WHWK) has 8 years of Change in Receivables data on file, last reported at $1.0 million in Q1 2025.
- Quarterly Change in Receivables rose 280.18% year-over-year to $1.0 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 140.96% YoY) and the FY2025 annual result came in at $1.0 million, up 140.96% from the prior year.
- Change in Receivables advanced to $1.0 million in Q1 2025 per WHWK's latest filing, from -$637000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $3.7 million in Q1 2023 and bottomed at -$14.0 million in Q1 2021.
- The 5-year median for Change in Receivables is -$120000.0 (2021), against an average of -$483066.7.
- The widest annual swing landed in 2022, when Change in Receivables sank 437.5%; it then surged 930.81% in 2023.
- Tracing WHWK's Change in Receivables over 5 years: stood at -$120000.0 in 2021, then plunged by 232.5% to -$399000.0 in 2022, then surged by 42.61% to -$229000.0 in 2023, then plunged by 178.17% to -$637000.0 in 2024, then soared by 256.99% to $1.0 million in 2025.
- Per Business Quant, the three latest WHWK Change in Receivables figures stand at $1.0 million (Q1 2025), -$637000.0 (Q4 2024), and $620000.0 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | -637,000.00 |
| Dec 31, 2024 | -637,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Mar 31, 2024 | -555,000.00 |
| Mar 31, 2024 | -555,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Sep 30, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | -1.89 Mn |
| Jun 30, 2023 | -1.89 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Dec 31, 2022 | -399,000.00 |
| Dec 31, 2022 | -399,000.00 |
| Sep 30, 2022 | 198,000.00 |
| Sep 30, 2022 | 198,000.00 |
| Jun 30, 2022 | -645,000.00 |
| Jun 30, 2022 | -645,000.00 |
| Mar 31, 2022 | 2.71 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Jun 30, 2021 | -120,000.00 |
| Jun 30, 2021 | -120,000.00 |
| Mar 31, 2021 | -14.03 Mn |
| Mar 31, 2021 | -14.03 Mn |
| Dec 31, 2020 | 13.92 Mn |
| Dec 31, 2020 | 13.92 Mn |
| Dec 31, 2017 | -39,246.00 |
| Dec 31, 2017 | -39,246.00 |
| Sep 30, 2017 | 34,982.00 |
| Sep 30, 2017 | 34,982.00 |
| Jun 30, 2017 | -28,189.00 |
| Jun 30, 2017 | -28,189.00 |
| Mar 31, 2017 | 28,296.00 |
| Mar 31, 2017 | 28,296.00 |
| Dec 31, 2016 | -4,960.00 |
| Dec 31, 2016 | -4,960.00 |
| Sep 30, 2016 | 4,544.00 |
| Sep 30, 2016 | 4,544.00 |
| Jun 30, 2016 | -50,486.00 |
| Jun 30, 2016 | -50,486.00 |
| Mar 31, 2016 | -63,457.00 |
| Mar 31, 2016 | -63,457.00 |